Hansoh Pharmaceutical
Chinese pharmaceutical company
From Wikipedia, the free encyclopedia
Hansoh Pharmaceutical Group Company Limited (simplified Chinese: 翰森制药集团有限公司; traditional Chinese: 翰森製藥集團有限公司; pinyin: Hànsēn Zhìyào Jítuán Yǒuxiàn Gōngsī) is a pharmaceutical company that manufactures and sells various types of medicine in mainland China.[1] It was founded in 1995 in Lianyungang, Jiangsu Province, China, by Zhong Huijuan, who is the company's chair.[2] Zhong and her family own 66% of the company.[3] It is the largest psychotropic drug producer in China.[4]
 | |
| Type | Public |
|---|---|
| SEHK: 3692 | |
| Industry | Pharmaceutical |
| Founded | 1995 |
| Founder | Zhong Huijuan |
| Headquarters | Shanghai, China |
Key people | Zhong Huijuan (CEO & Chairlady) |
| Website | www |
Hansoh Pharmaceutical had an initial public offering on the main board of the Hong Kong Stock Exchange (SEHK: 3692) on 14 June 2019.[5][6][7][8]
In August 2022, it was announced that the company's stock would be added to the Hang Seng Index.[9]